Apoglyx is a pre-clinical stage biotech company with the aim to develop a small molecule therapy for sepsis, and further indications, based on inhibition of Aquaporin-9.
Apoglyx was founded based on research from Aarhus University (DK), Aalborg University (DK), and Lund University (S).
Company Details
- Employees
- 5
- Founded
- 2015
- Address
- Medicon Village, Lund,skåne 22381,sweden
- pb****@****lyx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- apoglyx.com
- HQ
- Lund, Skåne
Apoglyx Questions
Apoglyx's website is apoglyx.com
Apoglyx's LinkedIn profile is https://se.linkedin.com/company/apoglyx
Apoglyx has
5 employees.
View email and phone details for 5
employees at Apoglyx.
Apoglyx's industry is
Biotechnology Research
Apoglyx's top competitors are
Bavarian Nordic,
Bactolife,
2n Pharma,
Proency,
Tetra Pharm Technologies,
Evodiabio,
Swedish Biomimetics 3000 Μlot Technology,
Alk,
2a Pharma,
Agb-Pharma Ab.
Apoglyx's support email address is pbn@apoglyx.com
Apoglyx's categories are Biotechnology Research
Apoglyx's founding year is 2015
